Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blocking the docking of HIV-1

Aine McKnight1, Robin A Weiss

  • 1Department of Immunology and Molecular Pathology, University College London, 46 Cleveland Street, London W1T 4JF, United Kingdom.

Proceedings of the National Academy of Sciences of the United States of America
|September 10, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice to "Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial" [J. Clin. Virol. 155C (2022) 105248].

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2025
Same author

Preservation of memory B cell homeostasis in an individual producing broadly neutralising antibodies against HIV-1.

bioRxiv : the preprint server for biology·2024
Same author

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.

The Lancet. Rheumatology·2024
Same author

The innate immune factor RPRD2/REAF and its role in the Lv2 restriction of HIV.

mBio·2023
Same author

Curbside particulate matter and susceptibility to SARS-CoV-2 infection.

The journal of allergy and clinical immunology. Global·2023
Same author

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity.

Nature communications·2023